Evaluación de Tecnología Sanitaria y su impacto en políticas de tarificación y cobertura de medicamentos

• Carla Castillo-Laborde ^[2] ; Nicolás Silva-Illanes ^[1]
  1. [1] Universidad de Chile

     Universidad de Chile

     Santiago, Chile

     
  2. [2] Ministerio de Desarrollo Social División Evaluación Social de Inversiones Departamento Metodologías
• Localización: Revista Médica de Chile, ISSN-e 0034-9887, Vol. 142, Nº. 0, 2014, págs. 33-38
• Idioma: español
• Títulos paralelos:
  • Health technology assessment and its impact on pharmaceutical pricing and reimbursement policies
• Enlaces
  • Texto completo
• Resumen

  • The article conceptualizes the pharmaceutical pricing and reimbursement policies related to financial coverage in the context of health systems. It introduces the pharmaceutical market as an imperfect one, in which appropriate regulation is required. Moreover, the basis that guide the pricing and reimbursement processes are defined and described in order to generate a categorization based on whether they are intended to assess the 'added value' and if the evaluation is based on cost-effectiveness criteria. This framework is used to review different types of these policies applied in the international context, discussing the role of the Health Technology Assessment in these processes. Finally, it briefly discusses the potential role of these types of policies in the Chilean context.